Conducting ETCTN Research

Once an ETCTN study is active at DF/HCC, the investigators and study team must conduct the study in accordance with both ETCTN and DF/HCC policies and procedures.  When a DF/HCC investigator is the national study chair s/he has additional responsibilities such as amending the protocol document, the informed consent and keeping the CIRB informed of study progress. Follow the menu items below that are most appropriate for your study.

 

DF/HCC Investigator is the National Study Chair

DF/HCC is a Participating Site

Participant Enrollment Yes Yes
Data Management  Yes Yes
Continuing Reviews Yes Yes
Amendments to CTEP Workflow Yes  N/A
Amendments to CTEP Guide  Yes  N/A
Amendments to OHRS Workflow  Yes Yes
Amendments to OHRS Guide  Yes Yes
Adverse Event Reporting Workflow  Yes Yes
Adverse Event Reporting Guide  Yes Yes
Drug Safety Notifications  Yes Yes